Restorative Neurostimulation Therapy Compared to Optimal Medical Management: A Randomized Evaluation (RESTORE) for the Treatment of Chronic Mechanical Low Back Pain due to Multifidus Dysfunction
Pain and Therapy · 2025-02 · 14 (1) · 401-423
DOI: 10.1007/s40122-024-00689-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pain and Therapy, online erschienen am 15.01.2025. Verfasst von Frank Schwab und 29 weiteren Autor:innen. Beteiligte Einrichtung: Northwell Health Orthopaedic Institute at Lenox Hill, 130 East 77th Street, Black Hall 7th, 11th, and 12th Floors, New York, NY, 10075, USA. fschwab@…. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Mainstay Medical.
Abstract (Originalsprache)
INTRODUCTION: Many interventional strategies are commonly used to treat chronic low back pain (CLBP), though few are specifically intended to target the distinct underlying pathomechanisms causing low back pain. Restorative neurostimulation has been suggested as a specific treatment for mechanical CLBP resulting from multifidus dysfunction. In this randomized controlled trial, we report outcomes from a cohort of patients with CLBP associated with multifidus dysfunction treated with restorative neurostimulation compared to those randomized to a control group receiving optimal medical management (OMM) over 1 year. METHODS: RESTORE is a multicenter, open-label randomized controlled trial. Candidates were assessed for CLBP associated with multifidus dysfunction, with no indication for or history of lumbar spine surgery. Participants were randomized to either restorative neurostimulation with the ReActiv8 system or OMM. The primary endpoint was a comparison of the mean change in the Oswestry Disability Index (ODI) between the treatment and control arms at 1 year, and secondary endpoints included pain (numeric rating scale [NRS]) and health-related quality of life (EuroQol Five-Dimension [EQ-5D-5L]). RESULTS: A total of 203 patients, average age 47 years, and with an average 11-year history of low back pain, were included in the analysis. The primary endpoint was a statistically significant demonstration of a clinically relevant mean improvement in the Oswestry Disability Index (ODI) between restorative neurostimulation and OMM arms: ODI (-19.7 ± 1.4 vs. -2.9 ± 1.4; p < 0.001). Additionally, improvements in both the numeric rating scale (NRS) (-3.6 ± 0.2 vs. -0.6 ± 0.2; p < 0.001) and EuroQol Five-Dimension (EQ-5D-5L) (0.155 ± 0.012 vs. 0.008 ± 0.012; p < 0.001) were statistically and clinically significant in the restorative neurostimulation arm compared to the OMM arm. CONCLUSION: The RESTORE trial demonstrates that restorative neurostimulation is a safe, reversible, clinically effective, and highly durable option for patients suffering with nonoperative CLBP associated with multifidus dysfunction. This demonstration of treatment superiority over OMM through 1 year is a significant milestone in addressing a major health burden and unmet clinical need. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04803214. Chronic low back pain can occur as a consequence of dysfunction in the key stabilizing muscles of the spine, the multifidi. This type of low back pain is difficult to treat, with many interventions resulting in limited improvement or short-term relief for a significant proportion of patients. Despite this limitation, these approaches still represent the best available care in most practices. Restorative neurostimulation is a technique that stimulates dysfunctional multifidi, overriding muscle inhibition to improve spinal function, reduce disability, and alleviate pain. The hypothesis was that this treatment is appropriate for a specific subset of patients who have failed to respond to best available conservative and interventional care. The goal of this study was to compare the effect of restorative neurostimulation to standard-of-care interventions (optimal medical management) for patients with chronic mechanical low back pain. Patients with an average 11-year history of chronic low back pain and diagnosed with multifidus dysfunction were randomly assigned to either ongoing optimal medical management or restorative neurostimulation. At 1 year, disability, pain, and healthcare-related quality of life were assessed. Patients treated with restorative neurostimulation demonstrated significant improvements in their clinical outcomes compared to those receiving optimal medical management alone. Device-related adverse events were rare, reinforcing the safety profile of this technique. This study demonstrated that without restorative neurostimulation, patients with chronic low back pain and multifidus dysfunction have very few effective options and obtained little clinical benefit from ongoing optimal medical management. Restorative neurostimulation is an important advancement for this difficult-to-treat population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Northwell Health Orthopaedic Institute at Lenox Hill, 130 East 77th Street, Black Hall 7th, 11th, and 12th Floors, New York, NY, 10075, USA. fschwab@northwell.edu.
- Cleveland Clinic, Cleveland, OH, USA.
- Northwell Health Pain Medicine, Anesthesiology, New York, NY, USA.
- OrthoIndy Hospital, Indianapolis, IN, USA.
- Spinal Diagnostics, Tualatin, OR, USA.
- Indiana Spine Group, Indianapolis, IN, USA.
Förderung
- Mainstay Medical
Zitieren
APA
Schwab, F., Mekhail, N., Patel, K. V., Langhorst, M., Heros, R. D., Gentile, J., Costandi, S., Moore, G., Gilmore, C., Manion, S., Chakravarthy, K., Meyer, S. C., Bundy, J. V., Tate, J. L., Sanders, R., Vaid, S., Szentirmai, O., Goree, J., Patel, V. V., …, & RESTORE investigators (2025). Restorative Neurostimulation Therapy Compared to Optimal Medical Management: A Randomized Evaluation (RESTORE) for the Treatment of Chronic Mechanical Low Back Pain due to Multifidus Dysfunction. Pain and Therapy, 14(1), 401-423. https://doi.org/10.1007/s40122-024-00689-0
Vancouver
Schwab F, Mekhail N, Patel KV, Langhorst M, Heros RD, Gentile J, et al. Restorative Neurostimulation Therapy Compared to Optimal Medical Management: A Randomized Evaluation (RESTORE) for the Treatment of Chronic Mechanical Low Back Pain due to Multifidus Dysfunction. Pain and Therapy. 2025;14(1):401-423. doi:10.1007/s40122-024-00689-0
BibTeX
@article{Schwab2025,
author = {Schwab, Frank and Mekhail, Nagy and Patel, Kiran V and Langhorst, Meredith and Heros, Robert D and Gentile, Jonathan and Costandi, Sherif and Moore, Gregory and Gilmore, Christopher and Manion, Smith and Chakravarthy, Krishnan and Meyer, S Craig and Bundy, Justin V and Tate, Jordan L and Sanders, Rebecca and Vaid, Sandeep and Szentirmai, Oszkar and Goree, Johnathan and Patel, Vikas V and Lehmen, Jeff and Desai, Mehul J and Pope, Jason E and Giuffrida, Anthony and Hayek, Salim and Virk, Sohrab Singh and Paicius, Richard and Klemme, William R and Levy, Robert and Gilligan, Christopher and RESTORE investigators, RESTORE investigators},
title = {Restorative Neurostimulation Therapy Compared to Optimal Medical Management: A Randomized Evaluation (RESTORE) for the Treatment of Chronic Mechanical Low Back Pain due to Multifidus Dysfunction},
journal = {Pain and Therapy},
year = {2025},
volume = {14},
number = {1},
pages = {401--423},
doi = {10.1007/s40122-024-00689-0}
}
EUVIMED